Skip to main content
. 2026 Jul 30;18(7):e113648. doi: 10.7759/cureus.113648

Table 1. Incidence of respiratory depression associated with intrathecal morphine across surgical types.

Abbreviations: ND: non-significant difference in incidence of respiratory depression between comparator arms (non-significant p-value); RR: respiratory rate; ITM: intrathecal morphine; SpO2: peripheral oxygen saturation; SaO2: arterial oxygen saturation; EREM: extended-release epidural morphine; PaCO2: arterial carbon dioxide tension; ASA: American Society of Anesthesiologists

Surgical Type Author Study Type # of Patients (n) ITM Dose Analgesic Outcomes Incidence of Respiratory Depression Respiratory Depression Definition
Spinal              
  Araimo Morselli et al. [55] Randomized controlled trial 50 100 µg ITM was associated with lower NRS scores, earlier mobilization, and shorter hospitalization than IV morphine. None SpO2 and arterial blood gas analysis
  Audlin et al. [87] Retrospective review 17 600 µg No statistical difference in postoperative pain or side effects noted between ITM, IV opioids, or oral opioids. None -
  De Bie et al. [57] Retrospective cohort study 60 100 µg ITM was associated with lower cumulative morphine consumption and VAS scores with earlier mobilization and earlier discharge compared to control. None -
  Sarwahi et al. [51] Retrospective review 373 1.5 µg/kg (avg 82.65 µg) ITM was associated with shorter length of stay, earlier ambulation, and lower VAS scores compared to control. None -
  Wang et al. [41] Randomized controlled trial 92 200 µg ITM was associated with lower VAS scores, PCA use, and supplemental analgesic demands with no increase in adverse effects compared to control. None -
  Yen et al. [116] Randomized controlled trial 32 3.5 µg/kg (350 µg max) ITM resulted in lower PCA use with no difference in pain scores compared to control. None RR < 9 breaths/min
  Ziegeler et al. [86] Randomized controlled trial 46 400 µg ITM resulted in improved VAS scores at rest 4 and 8 hours after surgery with significantly lower cumulative PCA requirements compared to control. None SaO2 and blood gas analysis
  Ibach et al. [112] Retrospective, cross-sectional, observational study 44 average 369 µg Patients experienced improved analgesia for at least 12 hours following ITM administration. 11.4% (5 patients) RR < 10 breaths/min
  Poblete et al. [85] Prospective proof-of-concept study 20 7 µg/kg (140-550 µg) ITM for postoperative analgesia after resection of cervical and thoracic spinal cord tumors was observed to be safe and effective. 5% (1 patient). Respiratory depression subsided quickly and without consequence or further intervention. RR < 8 breaths/min
  Cohen et al. [107] Randomized controlled trial 71 7.5 µg/kg (avg 402 µg) No difference in total morphine consumption or time until first PCA demand between EREM and ITM. EREM provided longer duration of analgesia and was associated with less opioid induced pruritus. ND in incidence between ITM vs extended-release epidural morphine (EREM). 24% (17 patients) of ITM pts, 15% (11 patients) of EREM pts. SpO2 < 88%
  Dhaliwal et al. [58] Randomized controlled trial 150 200 µg ITM was associated with reduced postoperative opioid requirements and VAS scores compared to control. ND in incidence between ITM vs sham saline injection. No significant differences in respiratory rates or oxygen saturation between treatment groups in the 24hrs postop. RR < 10 breaths/min
  Hong et al. [61] Retrospective review 40 12 µg/kg (avg 667.2 µg) Use of ITM in addition to routine administration of nonopioid analgesics facilitated early transition to oral analgesics, early ambulation, and early discharge compared to epidural hydromorphone. ND in incidence between ITM vs epidural hydromorphone. 33% of patients in both groups required nasal oxygen cannulation at some point after PACU discharge, however, none required naloxone or additional treatment for hypoxemia. SpO2 < 92%
Urologic              
  Swisher et al. [66] Retrospective case-control 27 300 µg ITM was associated with decreased opioid consumption and NRS scores compared to control. None -
  Park et al. [95] Retrospective review 366 200 µg ITM was associated with better functional recovery of remnant kidney in living donors with favorable analgesic results on NRS. None -
  Nuri Deniz et al. [65] Randomized controlled trial 56 200 µg ITM provided significant reduction in postoperative VAS scores, rescue analgesia, and postoperative nausea without serious adverse effects compared to control. None RR < 8 breaths/min
  Kurzova et al. [93] Randomized controlled trial 41 250 µg ITM provided long-lasting analgesia and reduction in postoperative systemic administration of opioids compared to control. Adverse effects were comparable between groups. None Bradypnea or SpO2 < 90%
  Kim et al. [92] Retrospective review 272 200 µg ITM was associated with lower NRS scores and cumulative opioid consumption compared to control. None -
  Kim et al. [62] Randomized controlled trial 45 300 µg ITM was associated with lower postoperative pain on NPS with significantly lower cumulative morphine consumption compared to control. None At least one of the following variables: respiratory rate < 8 breaths/min, ­SpO2 < 90% or PaCO2 > 70 mmHg
  Bae et al. [43] Randomized controlled trial 30 300 µg ITM was associated with lower NPS scores and cumulative morphine consumption compared to control. None At least one of the following variables: respiratory rate < 8 breaths/min, SpO2 < 90% or PaCO2 > 70 mmHg
  Boonmak et al. [56] Randomized controlled trial 80 300 µg ITM was associated with lower cumulative morphine consumption and NRS scores with no significant difference in patient satisfaction with pain management compared to control. None -
Thoracic              
  Askar et al. [44] Randomized controlled trial 33 10 µg/kg (avg 712.4 µg) ITM was associated with lower VAS scores and morphine consumption compared to control with better preservation of respiratory function. None -
  Okbaz et al. [77] Randomized controlled trial 46 7 µg/kg (avg 429.1µg) ITM at 10µg/kg was associated with lower postoperative morphine consumption and postoperative pain scores at 18 and 24 hours compared to ITM at 7µg/kg. None SpO2 < 90 on room air, RR <10 breaths/min, or Ramsay sedation scale score >3
10 µg/kg (avg 613 µg)
  Vijitpavan et al. [68] Randomized controlled trial 38 200 µg ITM was associated with lower NRS scores and cumulative dose of postoperative morphine compared to control. None RR < 8 breaths/min
  Ward et al. [76] Retrospective review 84 Initial injection 1000 µg, 2560 µg over 48hrs ITM was found to be an efficacious and safe analgesic method in post-thoracotomy patients with no serious complications or sequelae at 6-month follow up. None RR < 8 breaths/min and/or requiring naloxone
  Suksompong et al. [115] Randomized controlled trial 40 200 µg No statistical difference was found in 24-hours postoperative meperidine usage between groups. 5% (1 patient) in 300 µg group. Pt developed respiratory acidosis with RR 10 breaths/min 44 minutes after extubation. One patient in 300 µg group developed respiratory acidosis with RR 10 breaths/min 44 minutes after extubation
300 µg
Obstetric & Gynecological              
  Crowgey et al. [108] Retrospective review 5336 50-250 µg (avg 150 µg) The upper 95% confidence limit for respirator depression was found to be 0.07%. None Naloxone administration for reversal of RD
  Karaman et al. [34] Randomized controlled trial 24 5 µg/kg (avg 344 µg) ITM was associated with lower VAS scores, total morphine consumption, and systemic stress response compared to control. None RR < 10 breaths/min
  Bang et al. [101] Randomized controlled trial 68 200 µg ITM was associated with lower cumulative opioid consumption and higher patient satisfaction regarding pain control compared to control. ND in incidence between ITM and sham group – sham procedure involved 2 minutes of applied pressure with a capped needle without dural puncture. 6.1% (2 patients) of ITM group. 3% (1 patient) of sham group. RR < 8 breaths/min or need for supplemental oxygen to maintain SpO2 92%
Abdominal              
  Lee, S. et al. [114] Prospective randomized non-inferiority trial 55 300 µg ITM 300 µg exhibited non-inferior postoperative analgesia with lower incidence of PONV compared to 400 µg. None RR < 8 breaths/min or SpO2 < 90%
400 µg
  Niewiński et al. [64] Randomized controlled trial 36 400 µg No differences in NRS scores, pain severity, cumulative opioid consumption, or early recovery was observed between ITM and IV morphine. None -
  Blay et al. [37] Randomized controlled trial 32 200 µg ITM was associated with decreased intraoperative sufentanil, cumulative morphine consumption and VAS scores compared to control. None -
  De Pietri et al. [109] Retrospective case control 50 200 µg ITM was associated with lower cumulative morphine consumption and VAS scores, earlier mobilization, and earlier discharge compared to control. None Hypercapnia or hypoxia
  Ko et al. [39] Randomized controlled trial 40 400 µg ITM was associated with lower VAS scores and cumulative opioid consumption compared to control. None RR < 8 breaths/min
  Kuppusamy et al. [50] Randomized controlled trial 60 200 µg ITM was associated with lower cumulative morphine consumption compared to control. There was no statistically significant difference in VAS scores. None RR < 8 breaths/min or SpO2 < 90%
  Beaussier et al. [45] Randomized controlled trial 52 300 µg ITM was associated with decreased pain intensity and daily IV morphine consumption compared to control. 7.7% (4 patients). 1 pt experienced deep sedation with respiratory depression and inhalation of gastric contents. RR < 10 breaths/min
  Fares et al. [80] Randomized controlled trial 90 200 µg Time to first analgesic request was prolonged with 500 µg and 1000 µg compared to 200 µg. Mean tramadol consumption was lower with 500 µg and 1000 µg compared to 200 µg. VAS scores were lower with 1000 µg compared to 500 µg and 200 µg. 3.3% (1 patient) in 1000 µg group. Pt was 65 years old, frail, and ASA III. RR < 10 breaths/min
500 µg
1000 µg
  Mittal et al. [40] Randomized controlled trial 60 200 µg ITM was associated with lower NRS scores, cumulative fentanyl consumption, and lower total rescue analgesia compared to control. 13.3% (4 patients) in ITM group, 3.7% (1 patient) in control group. SpO2 < 92%
  Dichtwald et al. [110] Randomized controlled trial 49 4 µg/kg (avg 288 µg) ITM was associated with lower NRS scores and reduced need for rescue analgesia compared to IV opioids. ND in incidence between ITM vs IV remifentanil. 3% of all patients had non-life-threatening respiratory depression. RR < 10 breaths/min and/or PaCO2 > 60 mmHg
Abdominal, Urologic, or Thoracic              
  González-Santos et al. [111] Retrospective review 484 180 µg average (400 µg max) 51.03% of patients required postoperative rescue analgesia with IV morphine with an average dose of 6.98 mg, this was significantly higher in thoracic surgery patients compared to general surgery patients or urological surgery patients. None RR < 10 breaths/min, Sp02 < 90%, or signs of drowsiness/sedation
Cardiac              
  Dhawan et al. [55] Randomized controlled trial 79 5 µg/kg (avg 425 µg) ITM was associated with lower cumulative morphine equivalents, VAS scores, and percent of time in severe pain compared to control. None Prolonged tracheal reintubation secondary to hypercarbia or escalation of respiratory support after extubation secondary to hypercarbia
  dos Santos et al. [73] Randomized controlled trial 42 400 µg ITM was associated with lower VAS scores, cumulative morphine consumption, and plasma morphine concentration compared to control. None -
  Elgendy et al. [38] Randomized controlled trial 44 7 µg/kg (avg 392 µg) ITM was associated with lower VAS scores and cumulative fentanyl consumption, and mean tramadol consumption compared to control. Time to first request for rescue analgesia was prolonged with ITM. None RR < 10 breaths/min
  Mukherjee et al. [63] Randomized controlled trial 61 1.5 µg/kg (avg 118.5 µg) ITM was associated with decreased demand for IV opioids and VAS scores compared to IV opioids. None PaCO2 (limit not defined)
  Roediger et al [35] Randomized controlled trial 30 500 µg ITM was associated with a 40% reduction in IV morphine and lower VAS scores at rest compared to control. 26.7% (4 patients) in ITM group, 80% (12 patients) in control group. RR < 10 breaths/min
Breast              
  Karamese et al. [49] Randomized controlled trial 62 200 µg ITM was associated with lower cumulative morphine consumption than control; no different was noted in pain and satisfaction scores. None RR< 8 breaths/min and/or SpO2 < 90%
Non-surgical              
  Raffaeli et al. [102] Randomized controlled trial 144 15 µg Patients receiving ITM all experienced clinically significant pain relief on VAS scores with reduction in values ranging from 60% - 100%; only 25% of controls showed a reduction in VAS scores of over 50%. None RR < 6 breaths/min
30 µg
60 µg
250 µg
Pediatric              
  Keskin et al. [113] Retrospective observational cohort study 100 5 µg/kg (300 µg max) 96% of patients did not require rescue analgesia, sleep interruption was not observed in 97% of cases, and nurses were satisfied or very satisfied with pain management in 99% of cases. None RR < 18 breaths/min in patients < 10 years old; RR < 14 breaths/min in patients > 10 years old; PaCO2 above 45 mmHg